Global HIV Diagnostics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global HIV Diagnostics market size was valued at US$ 2578.9 million in 2023. With growing demand in downstream market, the HIV Diagnostics is forecast to a readjusted size of US$ 4660.9 million by 2030 with a CAGR of 8.8% during review period.
The research report highlights the growth potential of the global HIV Diagnostics market. HIV Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of HIV Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the HIV Diagnostics market.
The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on HIV Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the HIV Diagnostics market. It may include historical data, market segmentation by Type (e.g., Consumables, Assay, Kits and Reagents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the HIV Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the HIV Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the HIV Diagnostics industry. This include advancements in HIV Diagnostics technology, HIV Diagnostics new entrants, HIV Diagnostics new investment, and other innovations that are shaping the future of HIV Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the HIV Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for HIV Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the HIV Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting HIV Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the HIV Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the HIV Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the HIV Diagnostics market.
Market Segmentation:
HIV Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global HIV Diagnostics market size was valued at US$ 2578.9 million in 2023. With growing demand in downstream market, the HIV Diagnostics is forecast to a readjusted size of US$ 4660.9 million by 2030 with a CAGR of 8.8% during review period.
The research report highlights the growth potential of the global HIV Diagnostics market. HIV Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of HIV Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the HIV Diagnostics market.
The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on HIV Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the HIV Diagnostics market. It may include historical data, market segmentation by Type (e.g., Consumables, Assay, Kits and Reagents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the HIV Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the HIV Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the HIV Diagnostics industry. This include advancements in HIV Diagnostics technology, HIV Diagnostics new entrants, HIV Diagnostics new investment, and other innovations that are shaping the future of HIV Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the HIV Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for HIV Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the HIV Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting HIV Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the HIV Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the HIV Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the HIV Diagnostics market.
Market Segmentation:
HIV Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Consumables
- Assay, Kits and Reagents
- Other Consumables
- Instruments
- Software and Services
- Antibody Tests
- Viral Load Tests
- CD4 Tests
- Tests for Early Infant Diagnosis
- Tests for Viral Identification
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Abbott Healthcare
- Abbvie Inc.
- Brsitol-Myers Squibb
- Janssen Therapeutics
- Gilead Sciences
- Merck & Co. Inc
- VIIV Healthcare
- BD Biosciences
- Beckman Coulter
- Partec
- Sysmex
- Apogee Flow Systems
- PointCare Technologies Inc.
- Zyomyx Inc.
- Mylan inc.
- Roche Diagnostics
- Siemens Healthcare
- Qiagen
- BioMerieux
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HIV Diagnostics Market Size 2019-2030
2.1.2 HIV Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 HIV Diagnostics Segment by Type
2.2.1 Consumables
2.2.2 Assay, Kits and Reagents
2.2.3 Other Consumables
2.2.4 Instruments
2.2.5 Software and Services
2.3 HIV Diagnostics Market Size by Type
2.3.1 HIV Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global HIV Diagnostics Market Size Market Share by Type (2019-2024)
2.4 HIV Diagnostics Segment by Application
2.4.1 Antibody Tests
2.4.2 Viral Load Tests
2.4.3 CD4 Tests
2.4.4 Tests for Early Infant Diagnosis
2.4.5 Tests for Viral Identification
2.5 HIV Diagnostics Market Size by Application
2.5.1 HIV Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global HIV Diagnostics Market Size Market Share by Application (2019-2024)
3 HIV DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 HIV Diagnostics Market Size Market Share by Players
3.1.1 Global HIV Diagnostics Revenue by Players (2019-2024)
3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global HIV Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HIV DIAGNOSTICS BY REGIONS
4.1 HIV Diagnostics Market Size by Regions (2019-2024)
4.2 Americas HIV Diagnostics Market Size Growth (2019-2024)
4.3 APAC HIV Diagnostics Market Size Growth (2019-2024)
4.4 Europe HIV Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa HIV Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas HIV Diagnostics Market Size by Country (2019-2024)
5.2 Americas HIV Diagnostics Market Size by Type (2019-2024)
5.3 Americas HIV Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HIV Diagnostics Market Size by Region (2019-2024)
6.2 APAC HIV Diagnostics Market Size by Type (2019-2024)
6.3 APAC HIV Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe HIV Diagnostics by Country (2019-2024)
7.2 Europe HIV Diagnostics Market Size by Type (2019-2024)
7.3 Europe HIV Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HIV Diagnostics by Region (2019-2024)
8.2 Middle East & Africa HIV Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa HIV Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HIV DIAGNOSTICS MARKET FORECAST
10.1 Global HIV Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global HIV Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas HIV Diagnostics Forecast
10.1.3 APAC HIV Diagnostics Forecast
10.1.4 Europe HIV Diagnostics Forecast
10.1.5 Middle East & Africa HIV Diagnostics Forecast
10.2 Americas HIV Diagnostics Forecast by Country (2025-2030)
10.2.1 United States HIV Diagnostics Market Forecast
10.2.2 Canada HIV Diagnostics Market Forecast
10.2.3 Mexico HIV Diagnostics Market Forecast
10.2.4 Brazil HIV Diagnostics Market Forecast
10.3 APAC HIV Diagnostics Forecast by Region (2025-2030)
10.3.1 China HIV Diagnostics Market Forecast
10.3.2 Japan HIV Diagnostics Market Forecast
10.3.3 Korea HIV Diagnostics Market Forecast
10.3.4 Southeast Asia HIV Diagnostics Market Forecast
10.3.5 India HIV Diagnostics Market Forecast
10.3.6 Australia HIV Diagnostics Market Forecast
10.4 Europe HIV Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany HIV Diagnostics Market Forecast
10.4.2 France HIV Diagnostics Market Forecast
10.4.3 UK HIV Diagnostics Market Forecast
10.4.4 Italy HIV Diagnostics Market Forecast
10.4.5 Russia HIV Diagnostics Market Forecast
10.5 Middle East & Africa HIV Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt HIV Diagnostics Market Forecast
10.5.2 South Africa HIV Diagnostics Market Forecast
10.5.3 Israel HIV Diagnostics Market Forecast
10.5.4 Turkey HIV Diagnostics Market Forecast
10.5.5 GCC Countries HIV Diagnostics Market Forecast
10.6 Global HIV Diagnostics Forecast by Type (2025-2030)
10.7 Global HIV Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott HIV Diagnostics Product Offered
11.1.3 Abbott HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Abbott Healthcare
11.2.1 Abbott Healthcare Company Information
11.2.2 Abbott Healthcare HIV Diagnostics Product Offered
11.2.3 Abbott Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Abbott Healthcare Main Business Overview
11.2.5 Abbott Healthcare Latest Developments
11.3 Abbvie Inc.
11.3.1 Abbvie Inc. Company Information
11.3.2 Abbvie Inc. HIV Diagnostics Product Offered
11.3.3 Abbvie Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abbvie Inc. Main Business Overview
11.3.5 Abbvie Inc. Latest Developments
11.4 Brsitol-Myers Squibb
11.4.1 Brsitol-Myers Squibb Company Information
11.4.2 Brsitol-Myers Squibb HIV Diagnostics Product Offered
11.4.3 Brsitol-Myers Squibb HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Brsitol-Myers Squibb Main Business Overview
11.4.5 Brsitol-Myers Squibb Latest Developments
11.5 Janssen Therapeutics
11.5.1 Janssen Therapeutics Company Information
11.5.2 Janssen Therapeutics HIV Diagnostics Product Offered
11.5.3 Janssen Therapeutics HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Janssen Therapeutics Main Business Overview
11.5.5 Janssen Therapeutics Latest Developments
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Information
11.6.2 Gilead Sciences HIV Diagnostics Product Offered
11.6.3 Gilead Sciences HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Gilead Sciences Main Business Overview
11.6.5 Gilead Sciences Latest Developments
11.7 Merck & Co. Inc
11.7.1 Merck & Co. Inc Company Information
11.7.2 Merck & Co. Inc HIV Diagnostics Product Offered
11.7.3 Merck & Co. Inc HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Merck & Co. Inc Main Business Overview
11.7.5 Merck & Co. Inc Latest Developments
11.8 VIIV Healthcare
11.8.1 VIIV Healthcare Company Information
11.8.2 VIIV Healthcare HIV Diagnostics Product Offered
11.8.3 VIIV Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 VIIV Healthcare Main Business Overview
11.8.5 VIIV Healthcare Latest Developments
11.9 BD Biosciences
11.9.1 BD Biosciences Company Information
11.9.2 BD Biosciences HIV Diagnostics Product Offered
11.9.3 BD Biosciences HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 BD Biosciences Main Business Overview
11.9.5 BD Biosciences Latest Developments
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Information
11.10.2 Beckman Coulter HIV Diagnostics Product Offered
11.10.3 Beckman Coulter HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Beckman Coulter Main Business Overview
11.10.5 Beckman Coulter Latest Developments
11.11 Partec
11.11.1 Partec Company Information
11.11.2 Partec HIV Diagnostics Product Offered
11.11.3 Partec HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Partec Main Business Overview
11.11.5 Partec Latest Developments
11.12 Sysmex
11.12.1 Sysmex Company Information
11.12.2 Sysmex HIV Diagnostics Product Offered
11.12.3 Sysmex HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sysmex Main Business Overview
11.12.5 Sysmex Latest Developments
11.13 Apogee Flow Systems
11.13.1 Apogee Flow Systems Company Information
11.13.2 Apogee Flow Systems HIV Diagnostics Product Offered
11.13.3 Apogee Flow Systems HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Apogee Flow Systems Main Business Overview
11.13.5 Apogee Flow Systems Latest Developments
11.14 PointCare Technologies Inc.
11.14.1 PointCare Technologies Inc. Company Information
11.14.2 PointCare Technologies Inc. HIV Diagnostics Product Offered
11.14.3 PointCare Technologies Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 PointCare Technologies Inc. Main Business Overview
11.14.5 PointCare Technologies Inc. Latest Developments
11.15 Zyomyx Inc.
11.15.1 Zyomyx Inc. Company Information
11.15.2 Zyomyx Inc. HIV Diagnostics Product Offered
11.15.3 Zyomyx Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Zyomyx Inc. Main Business Overview
11.15.5 Zyomyx Inc. Latest Developments
11.16 Mylan inc.
11.16.1 Mylan inc. Company Information
11.16.2 Mylan inc. HIV Diagnostics Product Offered
11.16.3 Mylan inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Mylan inc. Main Business Overview
11.16.5 Mylan inc. Latest Developments
11.17 Roche Diagnostics
11.17.1 Roche Diagnostics Company Information
11.17.2 Roche Diagnostics HIV Diagnostics Product Offered
11.17.3 Roche Diagnostics HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Roche Diagnostics Main Business Overview
11.17.5 Roche Diagnostics Latest Developments
11.18 Siemens Healthcare
11.18.1 Siemens Healthcare Company Information
11.18.2 Siemens Healthcare HIV Diagnostics Product Offered
11.18.3 Siemens Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Siemens Healthcare Main Business Overview
11.18.5 Siemens Healthcare Latest Developments
11.19 Qiagen
11.19.1 Qiagen Company Information
11.19.2 Qiagen HIV Diagnostics Product Offered
11.19.3 Qiagen HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Qiagen Main Business Overview
11.19.5 Qiagen Latest Developments
11.20 BioMerieux
11.20.1 BioMerieux Company Information
11.20.2 BioMerieux HIV Diagnostics Product Offered
11.20.3 BioMerieux HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 BioMerieux Main Business Overview
11.20.5 BioMerieux Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HIV Diagnostics Market Size 2019-2030
2.1.2 HIV Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 HIV Diagnostics Segment by Type
2.2.1 Consumables
2.2.2 Assay, Kits and Reagents
2.2.3 Other Consumables
2.2.4 Instruments
2.2.5 Software and Services
2.3 HIV Diagnostics Market Size by Type
2.3.1 HIV Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global HIV Diagnostics Market Size Market Share by Type (2019-2024)
2.4 HIV Diagnostics Segment by Application
2.4.1 Antibody Tests
2.4.2 Viral Load Tests
2.4.3 CD4 Tests
2.4.4 Tests for Early Infant Diagnosis
2.4.5 Tests for Viral Identification
2.5 HIV Diagnostics Market Size by Application
2.5.1 HIV Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global HIV Diagnostics Market Size Market Share by Application (2019-2024)
3 HIV DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 HIV Diagnostics Market Size Market Share by Players
3.1.1 Global HIV Diagnostics Revenue by Players (2019-2024)
3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global HIV Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HIV DIAGNOSTICS BY REGIONS
4.1 HIV Diagnostics Market Size by Regions (2019-2024)
4.2 Americas HIV Diagnostics Market Size Growth (2019-2024)
4.3 APAC HIV Diagnostics Market Size Growth (2019-2024)
4.4 Europe HIV Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa HIV Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas HIV Diagnostics Market Size by Country (2019-2024)
5.2 Americas HIV Diagnostics Market Size by Type (2019-2024)
5.3 Americas HIV Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HIV Diagnostics Market Size by Region (2019-2024)
6.2 APAC HIV Diagnostics Market Size by Type (2019-2024)
6.3 APAC HIV Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe HIV Diagnostics by Country (2019-2024)
7.2 Europe HIV Diagnostics Market Size by Type (2019-2024)
7.3 Europe HIV Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HIV Diagnostics by Region (2019-2024)
8.2 Middle East & Africa HIV Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa HIV Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HIV DIAGNOSTICS MARKET FORECAST
10.1 Global HIV Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global HIV Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas HIV Diagnostics Forecast
10.1.3 APAC HIV Diagnostics Forecast
10.1.4 Europe HIV Diagnostics Forecast
10.1.5 Middle East & Africa HIV Diagnostics Forecast
10.2 Americas HIV Diagnostics Forecast by Country (2025-2030)
10.2.1 United States HIV Diagnostics Market Forecast
10.2.2 Canada HIV Diagnostics Market Forecast
10.2.3 Mexico HIV Diagnostics Market Forecast
10.2.4 Brazil HIV Diagnostics Market Forecast
10.3 APAC HIV Diagnostics Forecast by Region (2025-2030)
10.3.1 China HIV Diagnostics Market Forecast
10.3.2 Japan HIV Diagnostics Market Forecast
10.3.3 Korea HIV Diagnostics Market Forecast
10.3.4 Southeast Asia HIV Diagnostics Market Forecast
10.3.5 India HIV Diagnostics Market Forecast
10.3.6 Australia HIV Diagnostics Market Forecast
10.4 Europe HIV Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany HIV Diagnostics Market Forecast
10.4.2 France HIV Diagnostics Market Forecast
10.4.3 UK HIV Diagnostics Market Forecast
10.4.4 Italy HIV Diagnostics Market Forecast
10.4.5 Russia HIV Diagnostics Market Forecast
10.5 Middle East & Africa HIV Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt HIV Diagnostics Market Forecast
10.5.2 South Africa HIV Diagnostics Market Forecast
10.5.3 Israel HIV Diagnostics Market Forecast
10.5.4 Turkey HIV Diagnostics Market Forecast
10.5.5 GCC Countries HIV Diagnostics Market Forecast
10.6 Global HIV Diagnostics Forecast by Type (2025-2030)
10.7 Global HIV Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott HIV Diagnostics Product Offered
11.1.3 Abbott HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Abbott Healthcare
11.2.1 Abbott Healthcare Company Information
11.2.2 Abbott Healthcare HIV Diagnostics Product Offered
11.2.3 Abbott Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Abbott Healthcare Main Business Overview
11.2.5 Abbott Healthcare Latest Developments
11.3 Abbvie Inc.
11.3.1 Abbvie Inc. Company Information
11.3.2 Abbvie Inc. HIV Diagnostics Product Offered
11.3.3 Abbvie Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abbvie Inc. Main Business Overview
11.3.5 Abbvie Inc. Latest Developments
11.4 Brsitol-Myers Squibb
11.4.1 Brsitol-Myers Squibb Company Information
11.4.2 Brsitol-Myers Squibb HIV Diagnostics Product Offered
11.4.3 Brsitol-Myers Squibb HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Brsitol-Myers Squibb Main Business Overview
11.4.5 Brsitol-Myers Squibb Latest Developments
11.5 Janssen Therapeutics
11.5.1 Janssen Therapeutics Company Information
11.5.2 Janssen Therapeutics HIV Diagnostics Product Offered
11.5.3 Janssen Therapeutics HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Janssen Therapeutics Main Business Overview
11.5.5 Janssen Therapeutics Latest Developments
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Information
11.6.2 Gilead Sciences HIV Diagnostics Product Offered
11.6.3 Gilead Sciences HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Gilead Sciences Main Business Overview
11.6.5 Gilead Sciences Latest Developments
11.7 Merck & Co. Inc
11.7.1 Merck & Co. Inc Company Information
11.7.2 Merck & Co. Inc HIV Diagnostics Product Offered
11.7.3 Merck & Co. Inc HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Merck & Co. Inc Main Business Overview
11.7.5 Merck & Co. Inc Latest Developments
11.8 VIIV Healthcare
11.8.1 VIIV Healthcare Company Information
11.8.2 VIIV Healthcare HIV Diagnostics Product Offered
11.8.3 VIIV Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 VIIV Healthcare Main Business Overview
11.8.5 VIIV Healthcare Latest Developments
11.9 BD Biosciences
11.9.1 BD Biosciences Company Information
11.9.2 BD Biosciences HIV Diagnostics Product Offered
11.9.3 BD Biosciences HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 BD Biosciences Main Business Overview
11.9.5 BD Biosciences Latest Developments
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Information
11.10.2 Beckman Coulter HIV Diagnostics Product Offered
11.10.3 Beckman Coulter HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Beckman Coulter Main Business Overview
11.10.5 Beckman Coulter Latest Developments
11.11 Partec
11.11.1 Partec Company Information
11.11.2 Partec HIV Diagnostics Product Offered
11.11.3 Partec HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Partec Main Business Overview
11.11.5 Partec Latest Developments
11.12 Sysmex
11.12.1 Sysmex Company Information
11.12.2 Sysmex HIV Diagnostics Product Offered
11.12.3 Sysmex HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sysmex Main Business Overview
11.12.5 Sysmex Latest Developments
11.13 Apogee Flow Systems
11.13.1 Apogee Flow Systems Company Information
11.13.2 Apogee Flow Systems HIV Diagnostics Product Offered
11.13.3 Apogee Flow Systems HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Apogee Flow Systems Main Business Overview
11.13.5 Apogee Flow Systems Latest Developments
11.14 PointCare Technologies Inc.
11.14.1 PointCare Technologies Inc. Company Information
11.14.2 PointCare Technologies Inc. HIV Diagnostics Product Offered
11.14.3 PointCare Technologies Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 PointCare Technologies Inc. Main Business Overview
11.14.5 PointCare Technologies Inc. Latest Developments
11.15 Zyomyx Inc.
11.15.1 Zyomyx Inc. Company Information
11.15.2 Zyomyx Inc. HIV Diagnostics Product Offered
11.15.3 Zyomyx Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Zyomyx Inc. Main Business Overview
11.15.5 Zyomyx Inc. Latest Developments
11.16 Mylan inc.
11.16.1 Mylan inc. Company Information
11.16.2 Mylan inc. HIV Diagnostics Product Offered
11.16.3 Mylan inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Mylan inc. Main Business Overview
11.16.5 Mylan inc. Latest Developments
11.17 Roche Diagnostics
11.17.1 Roche Diagnostics Company Information
11.17.2 Roche Diagnostics HIV Diagnostics Product Offered
11.17.3 Roche Diagnostics HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Roche Diagnostics Main Business Overview
11.17.5 Roche Diagnostics Latest Developments
11.18 Siemens Healthcare
11.18.1 Siemens Healthcare Company Information
11.18.2 Siemens Healthcare HIV Diagnostics Product Offered
11.18.3 Siemens Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Siemens Healthcare Main Business Overview
11.18.5 Siemens Healthcare Latest Developments
11.19 Qiagen
11.19.1 Qiagen Company Information
11.19.2 Qiagen HIV Diagnostics Product Offered
11.19.3 Qiagen HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Qiagen Main Business Overview
11.19.5 Qiagen Latest Developments
11.20 BioMerieux
11.20.1 BioMerieux Company Information
11.20.2 BioMerieux HIV Diagnostics Product Offered
11.20.3 BioMerieux HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 BioMerieux Main Business Overview
11.20.5 BioMerieux Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. HIV Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Consumables
Table 3. Major Players of Assay, Kits and Reagents
Table 4. Major Players of Other Consumables
Table 5. Major Players of Instruments
Table 6. Major Players of Software and Services
Table 7. HIV Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global HIV Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global HIV Diagnostics Market Size Market Share by Type (2019-2024)
Table 10. HIV Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global HIV Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global HIV Diagnostics Market Size Market Share by Application (2019-2024)
Table 13. Global HIV Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global HIV Diagnostics Revenue Market Share by Player (2019-2024)
Table 15. HIV Diagnostics Key Players Head office and Products Offered
Table 16. HIV Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global HIV Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global HIV Diagnostics Market Size Market Share by Regions (2019-2024)
Table 21. Global HIV Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global HIV Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas HIV Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas HIV Diagnostics Market Size Market Share by Country (2019-2024)
Table 25. Americas HIV Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas HIV Diagnostics Market Size Market Share by Type (2019-2024)
Table 27. Americas HIV Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas HIV Diagnostics Market Size Market Share by Application (2019-2024)
Table 29. APAC HIV Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC HIV Diagnostics Market Size Market Share by Region (2019-2024)
Table 31. APAC HIV Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC HIV Diagnostics Market Size Market Share by Type (2019-2024)
Table 33. APAC HIV Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC HIV Diagnostics Market Size Market Share by Application (2019-2024)
Table 35. Europe HIV Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe HIV Diagnostics Market Size Market Share by Country (2019-2024)
Table 37. Europe HIV Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe HIV Diagnostics Market Size Market Share by Type (2019-2024)
Table 39. Europe HIV Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe HIV Diagnostics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa HIV Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa HIV Diagnostics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa HIV Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa HIV Diagnostics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa HIV Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa HIV Diagnostics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of HIV Diagnostics
Table 48. Key Market Challenges & Risks of HIV Diagnostics
Table 49. Key Industry Trends of HIV Diagnostics
Table 50. Global HIV Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global HIV Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global HIV Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global HIV Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Abbott Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 55. Abbott HIV Diagnostics Product Offered
Table 56. Abbott HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Abbott Main Business
Table 58. Abbott Latest Developments
Table 59. Abbott Healthcare Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 60. Abbott Healthcare HIV Diagnostics Product Offered
Table 61. Abbott Healthcare Main Business
Table 62. Abbott Healthcare HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Abbott Healthcare Latest Developments
Table 64. Abbvie Inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 65. Abbvie Inc. HIV Diagnostics Product Offered
Table 66. Abbvie Inc. Main Business
Table 67. Abbvie Inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Abbvie Inc. Latest Developments
Table 69. Brsitol-Myers Squibb Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 70. Brsitol-Myers Squibb HIV Diagnostics Product Offered
Table 71. Brsitol-Myers Squibb Main Business
Table 72. Brsitol-Myers Squibb HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Brsitol-Myers Squibb Latest Developments
Table 74. Janssen Therapeutics Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 75. Janssen Therapeutics HIV Diagnostics Product Offered
Table 76. Janssen Therapeutics Main Business
Table 77. Janssen Therapeutics HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Janssen Therapeutics Latest Developments
Table 79. Gilead Sciences Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 80. Gilead Sciences HIV Diagnostics Product Offered
Table 81. Gilead Sciences Main Business
Table 82. Gilead Sciences HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Gilead Sciences Latest Developments
Table 84. Merck & Co. Inc Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 85. Merck & Co. Inc HIV Diagnostics Product Offered
Table 86. Merck & Co. Inc Main Business
Table 87. Merck & Co. Inc HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Merck & Co. Inc Latest Developments
Table 89. VIIV Healthcare Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 90. VIIV Healthcare HIV Diagnostics Product Offered
Table 91. VIIV Healthcare Main Business
Table 92. VIIV Healthcare HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. VIIV Healthcare Latest Developments
Table 94. BD Biosciences Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 95. BD Biosciences HIV Diagnostics Product Offered
Table 96. BD Biosciences Main Business
Table 97. BD Biosciences HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. BD Biosciences Latest Developments
Table 99. Beckman Coulter Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 100. Beckman Coulter HIV Diagnostics Product Offered
Table 101. Beckman Coulter Main Business
Table 102. Beckman Coulter HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Beckman Coulter Latest Developments
Table 104. Partec Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 105. Partec HIV Diagnostics Product Offered
Table 106. Partec HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Partec Main Business
Table 108. Partec Latest Developments
Table 109. Sysmex Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 110. Sysmex HIV Diagnostics Product Offered
Table 111. Sysmex Main Business
Table 112. Sysmex HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Sysmex Latest Developments
Table 114. Apogee Flow Systems Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 115. Apogee Flow Systems HIV Diagnostics Product Offered
Table 116. Apogee Flow Systems Main Business
Table 117. Apogee Flow Systems HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Apogee Flow Systems Latest Developments
Table 119. PointCare Technologies Inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 120. PointCare Technologies Inc. HIV Diagnostics Product Offered
Table 121. PointCare Technologies Inc. Main Business
Table 122. PointCare Technologies Inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. PointCare Technologies Inc. Latest Developments
Table 124. Zyomyx Inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 125. Zyomyx Inc. HIV Diagnostics Product Offered
Table 126. Zyomyx Inc. Main Business
Table 127. Zyomyx Inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Zyomyx Inc. Latest Developments
Table 129. Mylan inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 130. Mylan inc. HIV Diagnostics Product Offered
Table 131. Mylan inc. Main Business
Table 132. Mylan inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Mylan inc. Latest Developments
Table 134. Roche Diagnostics Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 135. Roche Diagnostics HIV Diagnostics Product Offered
Table 136. Roche Diagnostics Main Business
Table 137. Roche Diagnostics HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Roche Diagnostics Latest Developments
Table 139. Siemens Healthcare Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 140. Siemens Healthcare HIV Diagnostics Product Offered
Table 141. Siemens Healthcare Main Business
Table 142. Siemens Healthcare HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Siemens Healthcare Latest Developments
Table 144. Qiagen Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 145. Qiagen HIV Diagnostics Product Offered
Table 146. Qiagen Main Business
Table 147. Qiagen HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Qiagen Latest Developments
Table 149. BioMerieux Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 150. BioMerieux HIV Diagnostics Product Offered
Table 151. BioMerieux Main Business
Table 152. BioMerieux HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. BioMerieux Latest Developments
Table 1. HIV Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Consumables
Table 3. Major Players of Assay, Kits and Reagents
Table 4. Major Players of Other Consumables
Table 5. Major Players of Instruments
Table 6. Major Players of Software and Services
Table 7. HIV Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global HIV Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global HIV Diagnostics Market Size Market Share by Type (2019-2024)
Table 10. HIV Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global HIV Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global HIV Diagnostics Market Size Market Share by Application (2019-2024)
Table 13. Global HIV Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global HIV Diagnostics Revenue Market Share by Player (2019-2024)
Table 15. HIV Diagnostics Key Players Head office and Products Offered
Table 16. HIV Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global HIV Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global HIV Diagnostics Market Size Market Share by Regions (2019-2024)
Table 21. Global HIV Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global HIV Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas HIV Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas HIV Diagnostics Market Size Market Share by Country (2019-2024)
Table 25. Americas HIV Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas HIV Diagnostics Market Size Market Share by Type (2019-2024)
Table 27. Americas HIV Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas HIV Diagnostics Market Size Market Share by Application (2019-2024)
Table 29. APAC HIV Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC HIV Diagnostics Market Size Market Share by Region (2019-2024)
Table 31. APAC HIV Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC HIV Diagnostics Market Size Market Share by Type (2019-2024)
Table 33. APAC HIV Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC HIV Diagnostics Market Size Market Share by Application (2019-2024)
Table 35. Europe HIV Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe HIV Diagnostics Market Size Market Share by Country (2019-2024)
Table 37. Europe HIV Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe HIV Diagnostics Market Size Market Share by Type (2019-2024)
Table 39. Europe HIV Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe HIV Diagnostics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa HIV Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa HIV Diagnostics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa HIV Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa HIV Diagnostics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa HIV Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa HIV Diagnostics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of HIV Diagnostics
Table 48. Key Market Challenges & Risks of HIV Diagnostics
Table 49. Key Industry Trends of HIV Diagnostics
Table 50. Global HIV Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global HIV Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global HIV Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global HIV Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Abbott Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 55. Abbott HIV Diagnostics Product Offered
Table 56. Abbott HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Abbott Main Business
Table 58. Abbott Latest Developments
Table 59. Abbott Healthcare Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 60. Abbott Healthcare HIV Diagnostics Product Offered
Table 61. Abbott Healthcare Main Business
Table 62. Abbott Healthcare HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Abbott Healthcare Latest Developments
Table 64. Abbvie Inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 65. Abbvie Inc. HIV Diagnostics Product Offered
Table 66. Abbvie Inc. Main Business
Table 67. Abbvie Inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Abbvie Inc. Latest Developments
Table 69. Brsitol-Myers Squibb Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 70. Brsitol-Myers Squibb HIV Diagnostics Product Offered
Table 71. Brsitol-Myers Squibb Main Business
Table 72. Brsitol-Myers Squibb HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Brsitol-Myers Squibb Latest Developments
Table 74. Janssen Therapeutics Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 75. Janssen Therapeutics HIV Diagnostics Product Offered
Table 76. Janssen Therapeutics Main Business
Table 77. Janssen Therapeutics HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Janssen Therapeutics Latest Developments
Table 79. Gilead Sciences Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 80. Gilead Sciences HIV Diagnostics Product Offered
Table 81. Gilead Sciences Main Business
Table 82. Gilead Sciences HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Gilead Sciences Latest Developments
Table 84. Merck & Co. Inc Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 85. Merck & Co. Inc HIV Diagnostics Product Offered
Table 86. Merck & Co. Inc Main Business
Table 87. Merck & Co. Inc HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Merck & Co. Inc Latest Developments
Table 89. VIIV Healthcare Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 90. VIIV Healthcare HIV Diagnostics Product Offered
Table 91. VIIV Healthcare Main Business
Table 92. VIIV Healthcare HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. VIIV Healthcare Latest Developments
Table 94. BD Biosciences Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 95. BD Biosciences HIV Diagnostics Product Offered
Table 96. BD Biosciences Main Business
Table 97. BD Biosciences HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. BD Biosciences Latest Developments
Table 99. Beckman Coulter Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 100. Beckman Coulter HIV Diagnostics Product Offered
Table 101. Beckman Coulter Main Business
Table 102. Beckman Coulter HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Beckman Coulter Latest Developments
Table 104. Partec Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 105. Partec HIV Diagnostics Product Offered
Table 106. Partec HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Partec Main Business
Table 108. Partec Latest Developments
Table 109. Sysmex Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 110. Sysmex HIV Diagnostics Product Offered
Table 111. Sysmex Main Business
Table 112. Sysmex HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Sysmex Latest Developments
Table 114. Apogee Flow Systems Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 115. Apogee Flow Systems HIV Diagnostics Product Offered
Table 116. Apogee Flow Systems Main Business
Table 117. Apogee Flow Systems HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Apogee Flow Systems Latest Developments
Table 119. PointCare Technologies Inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 120. PointCare Technologies Inc. HIV Diagnostics Product Offered
Table 121. PointCare Technologies Inc. Main Business
Table 122. PointCare Technologies Inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. PointCare Technologies Inc. Latest Developments
Table 124. Zyomyx Inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 125. Zyomyx Inc. HIV Diagnostics Product Offered
Table 126. Zyomyx Inc. Main Business
Table 127. Zyomyx Inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Zyomyx Inc. Latest Developments
Table 129. Mylan inc. Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 130. Mylan inc. HIV Diagnostics Product Offered
Table 131. Mylan inc. Main Business
Table 132. Mylan inc. HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Mylan inc. Latest Developments
Table 134. Roche Diagnostics Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 135. Roche Diagnostics HIV Diagnostics Product Offered
Table 136. Roche Diagnostics Main Business
Table 137. Roche Diagnostics HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Roche Diagnostics Latest Developments
Table 139. Siemens Healthcare Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 140. Siemens Healthcare HIV Diagnostics Product Offered
Table 141. Siemens Healthcare Main Business
Table 142. Siemens Healthcare HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Siemens Healthcare Latest Developments
Table 144. Qiagen Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 145. Qiagen HIV Diagnostics Product Offered
Table 146. Qiagen Main Business
Table 147. Qiagen HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Qiagen Latest Developments
Table 149. BioMerieux Details, Company Type, HIV Diagnostics Area Served and Its Competitors
Table 150. BioMerieux HIV Diagnostics Product Offered
Table 151. BioMerieux Main Business
Table 152. BioMerieux HIV Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. BioMerieux Latest Developments
LIST OF FIGURES
Figure 1. HIV Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HIV Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. HIV Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. HIV Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. HIV Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global HIV Diagnostics Market Size Market Share by Type in 2023
Figure 10. HIV Diagnostics in Antibody Tests
Figure 11. Global HIV Diagnostics Market: Antibody Tests (2019-2024) & ($ Millions)
Figure 12. HIV Diagnostics in Viral Load Tests
Figure 13. Global HIV Diagnostics Market: Viral Load Tests (2019-2024) & ($ Millions)
Figure 14. HIV Diagnostics in CD4 Tests
Figure 15. Global HIV Diagnostics Market: CD4 Tests (2019-2024) & ($ Millions)
Figure 16. HIV Diagnostics in Tests for Early Infant Diagnosis
Figure 17. Global HIV Diagnostics Market: Tests for Early Infant Diagnosis (2019-2024) & ($ Millions)
Figure 18. HIV Diagnostics in Tests for Viral Identification
Figure 19. Global HIV Diagnostics Market: Tests for Viral Identification (2019-2024) & ($ Millions)
Figure 20. Global HIV Diagnostics Market Size Market Share by Application in 2023
Figure 21. Global HIV Diagnostics Revenue Market Share by Player in 2023
Figure 22. Global HIV Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 23. Americas HIV Diagnostics Market Size 2019-2024 ($ Millions)
Figure 24. APAC HIV Diagnostics Market Size 2019-2024 ($ Millions)
Figure 25. Europe HIV Diagnostics Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa HIV Diagnostics Market Size 2019-2024 ($ Millions)
Figure 27. Americas HIV Diagnostics Value Market Share by Country in 2023
Figure 28. United States HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC HIV Diagnostics Market Size Market Share by Region in 2023
Figure 33. APAC HIV Diagnostics Market Size Market Share by Type in 2023
Figure 34. APAC HIV Diagnostics Market Size Market Share by Application in 2023
Figure 35. China HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. India HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe HIV Diagnostics Market Size Market Share by Country in 2023
Figure 42. Europe HIV Diagnostics Market Size Market Share by Type (2019-2024)
Figure 43. Europe HIV Diagnostics Market Size Market Share by Application (2019-2024)
Figure 44. Germany HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. France HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa HIV Diagnostics Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa HIV Diagnostics Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa HIV Diagnostics Market Size Market Share by Application (2019-2024)
Figure 52. Egypt HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. APAC HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Europe HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. United States HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Canada HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Mexico HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Brazil HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. China HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Japan HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Korea HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. India HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Australia HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Germany HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. France HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. UK HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. Italy HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Russia HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Spain HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. Egypt HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. South Africa HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 79. Israel HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 80. Turkey HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 82. Global HIV Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global HIV Diagnostics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. HIV Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HIV Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. HIV Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. HIV Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. HIV Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global HIV Diagnostics Market Size Market Share by Type in 2023
Figure 10. HIV Diagnostics in Antibody Tests
Figure 11. Global HIV Diagnostics Market: Antibody Tests (2019-2024) & ($ Millions)
Figure 12. HIV Diagnostics in Viral Load Tests
Figure 13. Global HIV Diagnostics Market: Viral Load Tests (2019-2024) & ($ Millions)
Figure 14. HIV Diagnostics in CD4 Tests
Figure 15. Global HIV Diagnostics Market: CD4 Tests (2019-2024) & ($ Millions)
Figure 16. HIV Diagnostics in Tests for Early Infant Diagnosis
Figure 17. Global HIV Diagnostics Market: Tests for Early Infant Diagnosis (2019-2024) & ($ Millions)
Figure 18. HIV Diagnostics in Tests for Viral Identification
Figure 19. Global HIV Diagnostics Market: Tests for Viral Identification (2019-2024) & ($ Millions)
Figure 20. Global HIV Diagnostics Market Size Market Share by Application in 2023
Figure 21. Global HIV Diagnostics Revenue Market Share by Player in 2023
Figure 22. Global HIV Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 23. Americas HIV Diagnostics Market Size 2019-2024 ($ Millions)
Figure 24. APAC HIV Diagnostics Market Size 2019-2024 ($ Millions)
Figure 25. Europe HIV Diagnostics Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa HIV Diagnostics Market Size 2019-2024 ($ Millions)
Figure 27. Americas HIV Diagnostics Value Market Share by Country in 2023
Figure 28. United States HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC HIV Diagnostics Market Size Market Share by Region in 2023
Figure 33. APAC HIV Diagnostics Market Size Market Share by Type in 2023
Figure 34. APAC HIV Diagnostics Market Size Market Share by Application in 2023
Figure 35. China HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. India HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe HIV Diagnostics Market Size Market Share by Country in 2023
Figure 42. Europe HIV Diagnostics Market Size Market Share by Type (2019-2024)
Figure 43. Europe HIV Diagnostics Market Size Market Share by Application (2019-2024)
Figure 44. Germany HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. France HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa HIV Diagnostics Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa HIV Diagnostics Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa HIV Diagnostics Market Size Market Share by Application (2019-2024)
Figure 52. Egypt HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country HIV Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. APAC HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Europe HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. United States HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Canada HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Mexico HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Brazil HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. China HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Japan HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Korea HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. India HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Australia HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Germany HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. France HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. UK HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. Italy HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Russia HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Spain HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. Egypt HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. South Africa HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 79. Israel HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 80. Turkey HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries HIV Diagnostics Market Size 2025-2030 ($ Millions)
Figure 82. Global HIV Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global HIV Diagnostics Market Size Market Share Forecast by Application (2025-2030)
